On average a healthy adult heart beats about 100,000 times a day.
Sometimes however, problems arise with the electrical impulses that
regulate the heart. This causes an irregular heartbeat—or cardiac
arrhythmia—a condition where the heart beats significantly slower,
faster or less efficiently than normal. A person with a cardiac
arrhythmia may experience symptoms that can reduce quality of life and
ultimately lead to a risk of sudden death. Examples of cardiac
arrhythmias include supraventricular arrhythmias, ventricular
tachycardia and atrial fibrillation.
Our Cardiac Arrhythmia Team
The management of an irregular heartbeat can span months or even years
and include a variety of treatments and procedural interventions.
Lankenau Heart Institute’s integrated approach to care allows
electrophysiologists, cardiac surgeons and advanced practitioners to
work together to provide a personalized treatment plan for each patient.
Members of the Lankenau Heart Institute’s cardiac
arrhythmia team are known worldwide for their experience in the
diagnosis and treatment of cardiac arrhythmias. They have made
significant contributions to the field through technological development
and their pioneering work has helped to advance new therapies and
As an international “show” site for leading medical technology
companies, Lankenau’s state-of-the-art electrophysiology lab
offers the latest integrated mapping and imaging systems
available. The pairing of this sophisticated equipment with the
skill and experience of the cardiac arrhythmia team ensures
exceptional care for the full range of heart rhythm disorders.
To ensure the best care, the Lankenau Heart Institute
electrophysiology service offers 24-hour-a-day monitoring using
remote management technology for patients who receive
implantable devices (including biventricular pacemakers and
ICDs). This service alerts our doctors to irregularities,
premature battery deficiency, and other cardiac events and
allows them to intervene quickly if a problem is detected.
Cardiac surgeons and electrophysiologists with the Lankenau
Heart Institute are experts in the use of minimally invasive
approaches to repair heart defects leading to atrial
fibrillation. Lankenau’s specialists are among only a handful in
the nation to offer the AtriClip procedure which has proven
effective in treating atrial fibrillation and preventing stroke.
Through the innovative use of advanced integrated mapping and
imaging systems during surgical procedures, they are achieving
the best possible results for patients.
The cardiac arrhythmia team provides a highly personal and
supportive environment for patients and their families. The team
cares for thousands of patients annually and performs more than
1,000 cardiac arrhythmia procedures each year—including over 400
catheter ablation procedures. Through the collaboration of
cardiologists and heart failure specialists the team ensures
that patients have access to the full spectrum of care.
A nationally recognized leader in the field, Dusan Kocovic, MD,
Chief, Section of Electrophysiology, at Lankenau has more than
20 years of clinical and research experience relative to ICDs
and radiofrequency ablation of ventricular tachycardia. He was
among the first in the U.S. to apply ICD technology in the
treatment of patients and headed research efforts that led to
the FDA’s approval of these devices in 2002. To date, Dr.
Kocovic has implanted more than 2,000 ICDs and performed more
than 1,000 complex ablations for atrial fibrillation (A-Fib) and
ventricular tachycardia (VT).
In 2012, Lankenau Heart Institute electrophysiologists performed
more than 400 cardiac ablations and 700 device implantations,
making the program one of the busiest on the East Coast.
The Choice for Cardiac Arrhythmia Treatment
The Lankenau Heart Institute’s cardiac arrhythmia program is widely
respected for its unique blend of experience, innovation and clinical
expertise. Its commitment to outcomes and patient care has led to the
State-of-the-art electrophysiology laboratories with the most
advanced technologies. This includes the verifiable mapping of
lesion sets when treating atrial fibrillation (A-Fib) with
surgical ablation, which has resulted in greater than 88 percent
of patients with persistent or long-term A-Fib returning to
An experienced and diverse team that is credentialed by the
Heart Rhythm Society and includes two board-certified female
Lankenau Heart Institute electrophysiologists perform more than
400 cardiac ablations and 700 device implantations, making the
program one of the busiest on the East Coast.
The team cares for thousands of patients annually and performs
more than 1,000 cardiac arrhythmia procedures each year. Through
the collaboration of cardiologists and heart
failure specialists the team ensures that patients have
access to the full spectrum of care.
A high degree of integration between electrophysiology and other
clinical specialties. Members of Lankenau’s cardiac surgery team
were the first in the region to use EP lab equipment in the
operating room to guide and test the effectiveness of ablation
lesions for the treatment of A-Fib.
Infection rates that are between four and five times below the
A commitment to developing novel treatment approaches for
biventricular pacing and ventricular tachycardia
Participation in groundbreaking clinical research such as the
Ongoing efforts to advance the field on a national and
international stage through work with pharmaceutical and device
companies and the Food and Drug Administration.
Research & Clinical Trials
Lankenau Heart Institute’s electrophysiologists are committed to
providing patients with individualized care and more advanced treatment
options, including the latest clinical trials.
For more information, call 1.866.CALL.MLH.